Ignite Creation Date:
2025-12-24 @ 4:00 PM
Ignite Modification Date:
2026-01-01 @ 10:39 PM
Study NCT ID:
NCT01347866
Status:
TERMINATED
Last Update Posted:
2018-10-29
First Post:
2011-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-02
First Submit QC Date:
None
Study First Post Date:
2011-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-15
Results First Submit QC Date:
None
Results First Post Date:
2018-10-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-13
Last Update Post Date:
2018-10-29
Last Update Post Date Type:
ACTUAL